Impaired health-related quality of life in Graves' disease. A prospective study

European Journal of Endocrinology

Volumn 151, Issue 5, 2004, Pages 549-555

  Elberling, T V ^a   Rasmussen, A K ^b   Feldt Rasmussen, U ^b   Hording M ^a   Perrild, H ^c   Waldemar, Gunhild ^a  

^a Mental Health Services CPH   (Denmark)

^b Rigshospitalet   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; LIOTHYRONINE; PERTECHNETIC ACID TC 99M; PROPYLTHIOURACIL; THIAMAZOLE; THYROID HORMONE; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ACUTE DISEASE; ADULT; AGE; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DEPRESSION; DISEASE ASSOCIATION; EDUCATION; ENDOCRINE OPHTHALMOPATHY; EUTHYROIDISM; FEMALE; GENDER; GRAVES DISEASE; HEALTH STATUS; HEALTH SURVEY; HUMAN; MALE; MENTAL DISEASE; PATIENT REFERRAL; PHYSICAL DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; QUALITY OF LIFE; RATING SCALE; SCORING SYSTEM; SOCIAL ASPECT; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; THYROTOXICOSIS; TREATMENT OUTCOME; VOLUNTEER;

ADULT; ANTITHYROID AGENTS; FEMALE; GRAVES DISEASE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 9444245845     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1510549     Document Type: Article

References (28)

1. Trzepacz PT, Klein I, Roberts M, Greenhouse J & Levey GS. Graves' disease: an analysis of thyroid hormone levels and hyperthyroid signs and symptoms. American Journal of Medicine 1989 87 558-561.
2. Kathol RG, Turner R & Delahunt J. Depression and anxiety associated with hyperthyroidism: response to antithyroid therapy. Psychosomatics 1986 27 501-505.
3. Trzepacz PT, McCue M, Klein I, Greenhouse J & Levey GS. Psychiatric and neuropsychological response to propranolol in Graves' disease. Biological Psychiatry 1988 23 678-688.
4. Paschke R, Harsch I, Schlote B, Vardarli I, Schaaf L, Kaumeier S, Teuber J & Usadel KH. Sequential psychological testing during the course of autoimmune hyperthyroidism. Klinische Wochenschrift 1990 68 942-950.
5. Sonino N, Girelli ME, Boscaro M, Fallo F, Busnardo B & Fava GA. Life events in the pathogenesis of Graves' disease. A controlled study. Acta Endocrinologica 1993 128 293-296.
6. Perrild H, Hansen JM, Arnung K, Olsen PZ & Danielsen U. Intellectual impairment after hyperthyroidism. Acta Endocrinologica (Copenhagen) 1986 112 185-191.
7. Bommer M, Eversmann T, Pickardt R, Leonhardt A & Naber D. Psychopathological and neuropsychological symptoms in patients with subclinical and remitted hyperthyroidism. Klinische Wochenschrift 1990 68 552-558.
8. Gerding MN, Terwee CB, Dekker FW, Koornneef L, Prummel MF & Wiersinga WM. Quality of life in patients with Graves' ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid 1997 7 885-889.
9. Egle UT, Kahaly GJ, Petrak F, Hardt J, Batke J, Best J & Rothenbacher M. The relevance of physical and psychosocial factors for the quality of life in patients with thyroid-associated orbitopathy (TAO). Experimental and Clinical Endocrinology and Diabetes 1999 107 S168-S171.
10. Kahaly GJ, Hardt J, Petrak F & Egle UT. Psychosocial factors in subjects with thyroid-associated ophthalmopathy. Thyroid 2002 12 237-239.
11. Terwee C, Wakelkamp I, Tan S, Dekker F, Prummel MF & Wiersinga W. Long-term effects of Graves' ophthalmopathy on health-related quality of life. European Journal of Endocrinology 2002 146 751-757.
12. Ware JE Jr & Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I Conceptual framework and item selection. Medical Care 1992 30 473-483.
13. Bjorner JB, Damsgaard MT, Watt T, Bech P, Rasmussen NK, Kristensen TS, Modvig J, Thundeborg K. Danish SF-36 Manual. Copenhagen: Lif, 1997.
14. Ware JE, Koskinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, MA: 1994.
15. Hamilton M. Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 1967 6 278-296.
16. Hamilton M. The assessment of anxiety states by rating. British Journal of Psychiatry 1959 32 50-55.
17. Hamilton M. Diagnosis and rating of anxiety. British Journal of Psychiatry 1969 3 76-79.
18. Bech P, Bolwig TG, Kramp P & Rafaelsen OJ. The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale. Acta Psychiatrica Scandinavica 1979 59 420-430.
19. Werner SC. Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. Journal of Clinical Endocrinology and Metabolism 1977 44 203-204.
20. Ware JE Jr. The SF-36 Health Survey. In Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd edn, ch 33, pp 337-345. Ed. B Spilker. Philadelphia: Lippincott-Raven, 1996.
21. Keller SD, Ware JE Jr, Bentler PM, Aaronson NK, Alonso J, Apolone G, Bjorner JB, Brazier J, Bullinger M, Kaasa S, Leplége A, Sullivan M & Gandek B. Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: results from the IQOLA Project. International Quality of Life Assessment. Journal of Clinical Epidemiology 1998 51 1179-1188.
22. Keller SD, Ware JE Jr, Gandek B, Aaronson NK, Alonso J, Apolone G, Bjorner JB, Brazier J, Bullinger M, Fukuhara S, Kaasa S, Leplége A, Sanson-Fisher RW, Sullivan M & Wood-Dauphinee S. Testing the equivalence of translations of widely used response choice labels: results from the IQOLA Project. International Quality of Life Assessment. Journal of Clinical Epidemiology 1998 51 933-944.
23. Raczek AE, Ware JE, Bjorner JB, Gandek B, Haley SM, Aaronson NK, Aaronson NK, Apolone G, Bech P, Brazier JE, Bullinger M & Sullivan M. Comparison of Rasch and summated rating scales constructed from SF-36 physical functioning items in seven countries: results from the IQOLA Project. International Quality of Life Assessment. Journal of Clinical Epidemiology 1998 51 1203-1214.
24. Rockey PH & Griep RJ. Behavioral dysfunction in hyperthyroidism. Improvement with treatment. Archives of Internal Medicine 1980 140 1194-1197.
25. Berg G, Michanek A, Holmberg E & Nystrom E. Clinical outcome of radioiodine treatment of hyperthyroidism: a follow-up study. Journal of Internal Medicine 1996 239 165-171.
26. Torring O, Tallstedt L, Wallin G, Lundell G, Ljunggren JG, Taube A, Sääf M & Hamberger B. Thyroid Study Group. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine - a prospective, randomized study. Thyroid Study Group. Journal of Clinical Endocrinology and Metabolism 1996 81 2986-2993.
27. Fahrenfort JJ, Wilterdink AM & van der Veen EA. Long-term residual complaints and psychosocial sequelae after remission of hyperthyroidism. Psychoneuroendocrinology 2000 25 201-211.
28. Biondi B, Palmieri EA, Fazio S, Cosco C, Nocera M, Sacca L, Filetti S, Lombardi G & Perticone F. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. Journal of Clinical Endocrinology and Metabolism 2000 85 4701-4705.